Kamal Adawi insider trades

Open-market stock purchases and sales by Kamal Adawi, Chief Financial Officer at Fate Therapeutics Inc, from SEC Form 4 filings since Sep 18, 2019.

Recent trades

DateStockTradeValue
Jan 15, 2026FATE Fate Therapeutics IncBought (not open market)—
Jan 15, 2026FATE Fate Therapeutics IncBought (not open market)—

Companies traded

  • FATE Fate Therapeutics Inc: other filings, last Jan 15, 2026
  • XGN Exagen Inc: 5 sales, last Mar 4, 2024

Get free alerts when Kamal Adawi files a new trade →